person
as of 2026-07-01Ann K Shinn, MD, MPH
at a glance
Roles: Principal Investigator, Author
KOL signal score 2
1 publications · 0 high-value
Cross-drug reach: 1 competitor drugs
Synthesized from structured facts only — each point cited above.
Profile
Affiliation
Mclean Hospital
Roles
Principal Investigator, Author
KOL signal
2
Publications
1 (0 high-value)
Trial investigator
no
Publishes on
1 drugs
Trials led
1
Publications & congress
1
Real-world use of xanomeline/trospium chloride in a large academic healthcare system in the first year following FDA approval.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · 2026
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
publishes on
PRINCIPAL_INVESTIGATOR